Int'l Warehouse
SARMS – MYOSTATIN® 5mg
Original price was: $67.00.$60.30Current price is: $60.30.
Brand Name : Beligas
Active Ingredients: YK-11
Tablet Count: 50 Tabs
SARMS-MYOSTATIN® 5mg
SARMS-Myostatin® 5mg, also referred to as YK-11, is a potent Selective Androgen Receptor Modulator (SARM) that functions as a myostatin inhibitor. This compound promotes muscle growth by suppressing myostatin, a protein that limits muscle development. It is favored by bodybuilders and athletes seeking significant muscle gains and improved physical performance.
How it works
Myostatin works by binding to androgen receptors and inhibiting the production of myostatin. This allows muscles to grow beyond their natural genetic limitations, resulting in enhanced muscle mass and strength. It also increases follistatin levels, a protein that plays a role in muscle growth and repair.
Proper Use and Dosage
The typical dosage for Myostatin is 5-10mg per day, often split into two doses. Beginners should start at 5mg daily to assess tolerance. A cycle typically lasts 6-8 weeks, followed by post-cycle therapy (PCT) to support hormonal recovery. It is commonly stacked with other SARMs for enhanced results.
Benefits
Myostatin provides exceptional muscle-building potential, helping users achieve significant gains in size and strength. It also enhances recovery, reduces muscle fatigue, and promotes a leaner, more defined physique. Its unique ability to surpass genetic muscle limits makes it a standout choice for advanced users.
Side Effects
Potential side effects of Myostatin include mild testosterone suppression, joint pain, or increased hair shedding. These effects are generally manageable with proper dosage, cycling, and the inclusion of PCT. Responsible use is crucial to minimizing risks and achieving optimal results.
Where to buy
Whenever bodybuilders want to buy steroids online and a reliable source, it’s always expected that the steroids shop they buy from – Finest Gears, for example – has the products they desire.
General Inquiries
There are no inquiries yet.
